Bharat Biotech concludes final analysis for Covaxin, claims 65.2% efficacy against Delta variant

The company said that Covaxin has shown 93.4% efficacy against severe infections.The vaccine has been proven 'safe' in India's largest efficacy trial, it said

from mint - News https://ift.tt/2UgkYAy
https://ift.tt/eA8V8J